JP2001064279A - New selenium compounds - Google Patents
New selenium compoundsInfo
- Publication number
- JP2001064279A JP2001064279A JP24168699A JP24168699A JP2001064279A JP 2001064279 A JP2001064279 A JP 2001064279A JP 24168699 A JP24168699 A JP 24168699A JP 24168699 A JP24168699 A JP 24168699A JP 2001064279 A JP2001064279 A JP 2001064279A
- Authority
- JP
- Japan
- Prior art keywords
- compound represented
- formula
- compound
- embedded image
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940065287 selenium compound Drugs 0.000 title claims abstract description 15
- 150000003343 selenium compounds Chemical class 0.000 title claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 81
- 238000004519 manufacturing process Methods 0.000 claims abstract description 17
- 239000011669 selenium Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 150000001451 organic peroxides Chemical class 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 11
- 235000018102 proteins Nutrition 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract description 3
- 230000001590 oxidative effect Effects 0.000 abstract description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 11
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 229910052711 selenium Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- GUUVPOWQJOLRAS-UHFFFAOYSA-N Diphenyl disulfide Chemical compound C=1C=CC=CC=1SSC1=CC=CC=C1 GUUVPOWQJOLRAS-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-YYWVXINBSA-N N,N-dimethylformamide-d7 Chemical compound [2H]C(=O)N(C([2H])([2H])[2H])C([2H])([2H])[2H] ZMXDDKWLCZADIW-YYWVXINBSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000009257 reactivity Effects 0.000 description 6
- YPGMOWHXEQDBBV-UHFFFAOYSA-N dithiane-4,5-diol Chemical compound OC1CSSCC1O YPGMOWHXEQDBBV-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- YQNGCXRVSYYNQS-UHFFFAOYSA-N selenolane-3,4-diol Chemical compound OC1C[Se]CC1O YQNGCXRVSYYNQS-UHFFFAOYSA-N 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- ZQTTTWIQXJBVAI-UHFFFAOYSA-N diselenane-4,5-diol Chemical compound OC1C[Se][Se]CC1O ZQTTTWIQXJBVAI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- -1 Glutathione oxide Chemical compound 0.000 description 1
- QPMSGKQJQQUGCE-UHFFFAOYSA-N OC(C[SeH])C(C[SeH])O Chemical compound OC(C[SeH])C(C[SeH])O QPMSGKQJQQUGCE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
(57)【要約】
【課題】蛋白質中のシステイン残基によるジスルフィド
結合を形成あるいは切断できる試薬(変成剤)としてD
TT(Dithiothreitol)およびその誘導
体である1,2−dithiane−4,5−diol
が広く知られているが、DTT等はpHに大きく依存
し、pH8.0以上のアルカリ性条件下のみで反応が進
行するため、生体内の環境に近い中性付近での反応をお
こなうことができなかった。
【解決手段】中性付近で反応性の高い変成剤として、下
記の式(1)で表される化合物とそれを還元することに
よって得られる式(2)で表される化合物、および式
(3)で表される化合物とそれを酸化することによって
得られる式(4)で表される化合物等の新規セレン化合
物、およびそれらの製造方法を見出した。
【化1】
【化2】
【化3】
【化4】
PROBLEM TO BE SOLVED: To provide a reagent (denaturing agent) capable of forming or cleaving a disulfide bond by a cysteine residue in a protein.
TT (Dithiothreitol) and its derivative 1,2-dithane-4,5-diol
Although DTT and the like are widely known, DTT and the like largely depend on pH, and the reaction proceeds only under alkaline conditions of pH 8.0 or more, so that a reaction near neutrality close to the in vivo environment can be performed. Did not. Kind Code: A1 A compound represented by the following formula (1), a compound represented by the formula (2) obtained by reducing it, and a compound represented by the formula (3), which are highly reactive near neutrality: ), A novel selenium compound such as a compound represented by the formula (4) obtained by oxidizing the compound, and a method for producing them. Embedded image Embedded image Embedded image Embedded image
Description
【0001】[0001]
【発明の属する技術分野】本発明は蛋白質中のシステイ
ン残基によるジスルフィド結合を形成あるいは切断でき
る試薬である新規なセレン化合物類とその製造方法に関
する。TECHNICAL FIELD The present invention relates to a novel selenium compound which is a reagent capable of forming or cleaving a disulfide bond by a cysteine residue in a protein, and a method for producing the same.
【0002】[0002]
【従来の技術】蛋白質中のシステイン残基によるジスル
フィド結合を形成あるいは切断できる試薬(変成剤)と
してはDTT(Dithiothreitol=1,4
−ジメルカプト−2,3−ブタンジオール)およびその
誘導体である1,2−ジチアン−4,5−ジオールが広
く知られている。これらDTT等は有用な試薬であり、
蛋白質の立体構造形成過程を研究する手法に幅広く利用
されている。2. Description of the Related Art As a reagent (denaturing agent) capable of forming or cleaving a disulfide bond by a cysteine residue in a protein, DTT (Dithiothreitol = 1,4) is known.
-Dimercapto-2,3-butanediol) and its derivative 1,2-dithiane-4,5-diol are widely known. These DTTs are useful reagents,
It is widely used for studying the process of protein three-dimensional structure formation.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、上記の
DTT等はpHに大きく依存し、pH8以上のアルカリ
性条件下のみで反応が進行するため、生体内の環境に近
い中性付近での反応をおこなうことができなかった。す
なわち、中性付近で反応性の高い変成剤の開発が望まれ
ている。However, the above-mentioned DTT and the like greatly depend on pH, and the reaction proceeds only under alkaline conditions of pH 8 or more, so that the reaction takes place near neutrality close to the in vivo environment. I couldn't do that. That is, there is a demand for the development of a modifying agent having high reactivity near neutrality.
【0004】[0004]
【課題を解決するための手段】本発明者らは、中性付近
で反応性の高い変成剤について鋭意研究した結果、下記
の式(1)で表される化合物とそれを還元することによ
って得られる式(2)で表される化合物、および式
(3)で表される化合物とそれを酸化することによって
得られる式(4)で表される化合物等の新規セレン化合
物類およびそれらの製造方法を見出した。Means for Solving the Problems The present inventors have conducted intensive studies on a modifying agent having high reactivity near neutrality, and as a result, obtained by reducing a compound represented by the following formula (1) and a compound represented by the following formula (1). Novel selenium compounds such as a compound represented by the formula (2), a compound represented by the formula (3) and a compound represented by the formula (4) obtained by oxidizing the compound, and methods for producing them Was found.
【0005】すなわち、本発明は下記の構成からなるも
のである。 [1]式(1)で表される化合物。That is, the present invention has the following constitution. [1] A compound represented by the formula (1).
【化6】 Embedded image
【0006】[2]式(2)で表される化合物。[2] A compound represented by the formula (2):
【化7】 Embedded image
【0007】[3]式(3)で表される化合物。[3] A compound represented by the formula (3):
【化8】 Embedded image
【0008】[4]式(4)で表される化合物。[4] A compound represented by the formula (4):
【化9】 Embedded image
【0009】[5]式(5)[5] Equation (5)
【化10】 で表される化合物に、一般式(6)で表されるセレン化
合物を作用させることを特徴とする、前記[1]項に記
載の式(1)で表される化合物の製造方法。 M2Se2 (6) (式中、MはLi,NaまたはKである。)Embedded image Wherein the selenium compound represented by the general formula (6) is caused to act on the compound represented by the general formula (6). M 2 Se 2 (6) (where M is Li, Na or K)
【0010】[6]前記[5]項において、一般式
(6)のMがNaである、前記[1]項に記載の式
(1)で表される化合物の製造方法。[6] The method for producing a compound represented by the formula (1) according to the above item [1], wherein M in the general formula (6) is Na in the item [5].
【0011】[7]前記[1]項に記載の式(1)で表
される化合物に、一般式(7)で表される還元剤を作用
させることを特徴とする、前記[2]項に記載の式
(2)で表される化合物の製造方法。 MBH4 (7) (式中、MはLi、NaまたはKである。)[7] The above item [2], wherein a compound represented by the general formula (7) is allowed to act on the compound represented by the formula (1) described in the above item [1]. A method for producing a compound represented by the formula (2) described in (1). MBH 4 (7) (where M is Li, Na or K)
【0012】[8]前記[7]項において、一般式
(7)のMがNaである、前記[2]項に記載の式
(2)で表される化合物の製造方法。[8] The method for producing a compound represented by the formula (2) according to the above item [2], wherein M in the general formula (7) is Na in the item [7].
【0013】[9]前記[5]項に記載の式(5)で表
される化合物に、一般式(8)で表されるセレン化合物
を作用させることを特徴とする、前記[3]項に記載の
式(3)で表される化合物の製造方法。 MHSe (8) (式中、MはLi,NaまたはKである。)[9] The item [3], wherein a selenium compound represented by the general formula (8) is allowed to act on the compound represented by the formula (5) described in the item [5]. The method for producing a compound represented by the formula (3) described in (1). MHSe (8) (where M is Li, Na or K)
【0014】[10]前記[9]項において、一般式
(8)のMがNaである、前記[3]項に記載の式
(3)で表される化合物の製造方法。[10] The method for producing a compound represented by the formula (3) according to the above item [3], wherein M in the general formula (8) is Na in the above item [9].
【0015】[11]前記[3]項に記載の式(3)で
表される化合物に、有機過酸化物を作用させることを特
徴とする、前記[4]項に記載の式(4)で表される化
合物の製造方法。[11] The compound represented by the formula (4) according to the above item [4], wherein an organic peroxide is allowed to act on the compound represented by the formula (3) according to the above item [3]. A method for producing a compound represented by the formula:
【0016】本発明が提供する蛋白質の変成剤として有
用な新規セレン化合物は、上記の式(1)で表される化
合物(以下、化合物(1)と略称する。)、式(2)で
表される化合物(以下、化合物(2)と略称する。)お
よび式(4)で表される化合物(以下、化合物(4)と
略称する。)である。また、式(3)で表される化合物
(以下、化合物(3)と略称する。)も新規に見出され
たものであり、これらはいずれも触媒としての作用も期
待される。The novel selenium compound useful as a protein denaturant provided by the present invention is a compound represented by the above formula (1) (hereinafter abbreviated as compound (1)) or a compound represented by the formula (2). (Hereinafter abbreviated as compound (2)) and a compound represented by the formula (4) (hereinafter abbreviated as compound (4)). Further, a compound represented by the formula (3) (hereinafter, abbreviated as compound (3)) has also been newly discovered, and all of them are expected to act as a catalyst.
【0017】[0017]
【発明の実施の形態】本発明の化合物は、それぞれ以下
の方法で製造される。化合物(1)は、式(5)で表さ
れる化合物トランス−1,3−ブタジエンジエポキシド
と上記の一般式(6)で表されるセレン化合物、例えば
Na2Se2を作用させ、下記のScheme1に示す反
応経路によって得ることが出来る。BEST MODE FOR CARRYING OUT THE INVENTION The compounds of the present invention are each produced by the following methods. The compound (1) is reacted with a compound trans-1,3-butadiene diepoxide represented by the formula (5) and a selenium compound represented by the above general formula (6), for example, Na 2 Se 2, and It can be obtained by the reaction route shown in Scheme 1.
【化11】 Embedded image
【0018】化合物(1)をメタノールに溶解し、上記
の一般式(7)で表される還元剤、例えば水素化ホウ素
ナトリウムで還元処理後、濃塩酸で処理することにより
化合物(2)に導くことが出来る(Scheme2)。The compound (1) is dissolved in methanol, reduced with a reducing agent represented by the general formula (7), for example, sodium borohydride, and then treated with concentrated hydrochloric acid to obtain the compound (2). (Scheme 2).
【化12】 Embedded image
【0019】上記の例は出発物質にトランス−ブタジエ
ンジエポキシドを用いているが、これをシス−ブタジエ
ンジエポキシドに変更することにより、シス体の化合物
(1)および(2)を得ることが出来る。In the above example, trans-butadiene diepoxide is used as a starting material, but cis-form compounds (1) and (2) can be obtained by changing this to cis-butadiene diepoxide. .
【0020】化合物(3)は、トランス−1,3−ブタ
ジエンジエポキシドと一般式(8)で表されるセレン化
合物、例えばNaHSeを作用させ、下記のSchem
e3に示す反応経路によって得ることが出来る。The compound (3) is reacted with trans-1,3-butadiene diepoxide and a selenium compound represented by the general formula (8), for example, NaHSe, to give the following Schem.
It can be obtained by the reaction route shown in e3.
【化13】 Embedded image
【0021】化合物(3)は、過蟻酸、過酢酸、過安息
香酸、メタクロロ過安息香酸、またはt-ブチルペルオキ
シドなどの有機過酸化物を用いて酸化することにより、
化合物(4)へと変換することが出来る(Scheme
4)。The compound (3) is oxidized by using an organic peroxide such as formic acid, peracetic acid, perbenzoic acid, metachloroperbenzoic acid, or t-butyl peroxide.
Can be converted to compound (4) (Scheme
4).
【化14】 Embedded image
【0022】上記の例も出発物質をトランス−ブタジエ
ンジエポキシドからシス−ブタジエンジエポキシドに変
更することにより、シス体の化合物(3)および(4)
を得ることが出来る。In the above example, the starting material was changed from trans-butadiene diepoxide to cis-butadiene diepoxide to obtain cis-form compounds (3) and (4).
Can be obtained.
【0023】上記の一般式(6)または(8)で表され
るセレン化合物は、金属セレンを水中に懸濁させ、一般
式(7)で表される還元剤と反応させることにより得る
ことができる。このとき、金属セレンと一般式(7)で
表される還元剤とのモル比を1:1にすれば一般式
(6)で表されるセレン化合物が得られ、1:2で反応
させれば一般式(8)で表されるセレン化合物が得られ
る。The selenium compound represented by the general formula (6) or (8) can be obtained by suspending metal selenium in water and reacting the metal selenium with a reducing agent represented by the general formula (7). it can. At this time, if the molar ratio of the metal selenium to the reducing agent represented by the general formula (7) is set to 1: 1, the selenium compound represented by the general formula (6) is obtained, and the reaction is performed at a ratio of 1: 2. For example, a selenium compound represented by the general formula (8) is obtained.
【0024】[0024]
【実施例】以下、実施例により本発明を更に詳しく説明
するが、本発明はこれらの実施例によって制限されるも
のではない。 実施例1 化合物(1)(1,2−ジセレナン−4,5−ジオー
ル)の合成 窒素気流下室温にて、セレン3.0g(38mmol)
を水25mLに懸濁させ、これに水素化ホウ素ナトリウ
ム3.0g(76mmol)を水25mLに溶かした溶
液をゆっくりと滴下した。10分後、セレン3.0g
(38mmol)を加え、更に15分間撹拌した。この
混合液をセレンが溶けるまで約1時間100℃で加熱し
た後室温になるまで冷却し、1,3−ブタジエンジエポ
キシド1.46mL(19mmol)を加えた。1時間
加熱還流の後、過剰の還元型セレン(Na2Se2)を酸
化するために空気中で一晩撹拌した。析出したセレンを
濾別後、水層をソックスレー抽出器を用いて連続エーテ
ル抽出し、目的化合物2.54gを得た。粗収率は54
%であった。得られた化合物(1)をメタノール5mL
より再結晶し、黄色柱状結晶を得た。EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention. Example 1 Synthesis of compound (1) (1,2-diselenane-4,5-diol) 3.0 g (38 mmol) of selenium at room temperature under a nitrogen stream.
Was suspended in 25 mL of water, and a solution of 3.0 g (76 mmol) of sodium borohydride dissolved in 25 mL of water was slowly added dropwise thereto. 10 minutes later, 3.0 g of selenium
(38 mmol) was added and the mixture was further stirred for 15 minutes. The mixture was heated at 100 ° C. for about 1 hour until selenium was dissolved, then cooled to room temperature, and 1.46 mL (19 mmol) of 1,3-butadiene diepoxide was added. After heating and refluxing for 1 hour, the mixture was stirred overnight in air to oxidize excess reduced selenium (Na 2 Se 2 ). After separating the precipitated selenium by filtration, the aqueous layer was subjected to continuous ether extraction using a Soxhlet extractor to obtain 2.54 g of the target compound. The crude yield is 54
%Met. 5 mL of the obtained compound (1) is methanol
Further recrystallization gave yellow columnar crystals.
【0025】 融点116〜118℃1 H-NMR (in DMF-d7):d 3.16(m,2H),3.43(dd,2H),3.5
3(m,2H),5.20(d,2H)13 C-NMR (in DMF-d7):d 31.8,75.477 Se-NMR (in DMF-d7):d 268 (broad) IR (流動パラフィン法):3450,3319,1448,1412,12
82,1248,1120,997,968,843,760cm-1 元素分析:C 19.59%,H 3.14% (calc. C 19.53%,H 3.
28%) 1 H-NMR (in DMF-d7): d 3.16 (m, 2H), 3.43 (dd, 2H), 3.5
3 (m, 2H), 5.20 (d, 2H) 13 C-NMR (in DMF-d7): d 31.8, 75.4 77 Se-NMR (in DMF-d7): d 268 (broad) IR (liquid paraffin method) : 3450, 3319, 1448, 1412, 12
82, 1248, 1120, 997, 968, 843, 760 cm- 1 Elemental analysis: C 19.59%, H 3.14% (calc. C 19.53%, H 3.
(28%)
【0026】実施例2 化合物(3)(セレノラン−3,4−ジオール)の合成 窒素気流下室温において、セレン1.5g(19mmo
l)を水25mLに懸濁させ、これに水素化ホウ素ナト
リウム1.5g(38mmol)を水25mLに溶かし
た溶液をゆっくりと滴下した。15分間撹拌後、1,3
−ブタジエンジエポキシド1.2mL(16mmol)
を加えた。10分間室温で撹拌後、窒素ラインを取り外
し、空気中で一晩撹拌した。析出したセレンを濾別後、
水層をソックスレーを用いて連続エーテル抽出し、セレ
ノラン−3,4−ジオール1.44gを得た。粗収率は
55%であった。さらにクロロホルム5mLで再結晶
し、白色柱状結晶を得た。Example 2 Synthesis of compound (3) (selenolan-3,4-diol) 1.5 g (19 mmol) of selenium at room temperature under a nitrogen stream.
l) was suspended in 25 mL of water, and a solution of 1.5 g (38 mmol) of sodium borohydride dissolved in 25 mL of water was slowly added dropwise. After stirring for 15 minutes,
-Butadiene diepoxide 1.2 mL (16 mmol)
Was added. After stirring at room temperature for 10 minutes, the nitrogen line was removed and the mixture was stirred in air overnight. After filtering off the precipitated selenium,
The aqueous layer was subjected to continuous ether extraction using Soxhlet to obtain 1.44 g of selenolane-3,4-diol. The crude yield was 55%. Further, recrystallization was performed with 5 mL of chloroform to obtain white columnar crystals.
【0027】融点79〜80℃1 H-NMR (in CDCl3):d 2.10(d,2H),2.87(dd,2H),3.16
(dd,2H),4.27(m,2H)13 C-NMR (in CDCl3):d 26.8,78.977 Se-NMR (in CDCl3):d 65.6 IR (流動パラフィン法):3305,1460,1377,1275,11
80,1134,1012,941,781cm-1 元素分析:C 28.55%,H 4.70% (calc. C 28.76%,H 4.
83%)[0027] mp 79~80 ℃ 1 H-NMR (in CDCl3): d 2.10 (d, 2H), 2.87 (dd, 2H), 3.16
(dd, 2H), 4.27 (m, 2H) 13 C-NMR (in CDCl 3): d 26.8, 78.9 77 Se-NMR (in CDCl 3): d 65.6 IR (liquid paraffin method): 3305, 1460, 1377, 1275 , 11
80, 1134, 1012, 941, 781 cm -1 Elemental analysis: C 28.55%, H 4.70% (calc. C 28.76%, H 4.
(83%)
【0028】実施例3 化合物(4)(3,4−ジヒドロキシ−1−セレノラン
オキシド)の合成 実施例2で得られたセレノラン−3,4−ジオール5
4.7mg(0.33mmol)を塩化メチレン10m
Lに溶解し、この溶液にm−クロロ過安息香酸56.3
mg(0.33mmol)を塩化メチレン10mLに溶
かした溶液を加えて撹拌した。生じた白色沈殿を濾過し
て集め、目的化合物41.1mgを得た。粗収率は69
%であった。さらにメタノールより再結晶して白色柱状
結晶を得た。Example 3 Synthesis of compound (4) (3,4-dihydroxy-1-selenolane oxide) Selenolane-3,4-diol 5 obtained in Example 2
4.7 mg (0.33 mmol) of methylene chloride 10m
L, and m-chloroperbenzoic acid 56.3 was added to this solution.
A solution of mg (0.33 mmol) in 10 mL of methylene chloride was added and stirred. The resulting white precipitate was collected by filtration to give 41.1 mg of the desired compound. The crude yield is 69
%Met. Recrystallization from methanol gave white columnar crystals.
【0029】融点123.8〜125.2℃1 H-NMR (in CDCl3):d 2.87(d,1H),3.08(dd,1H),3.58
(dd,1H),3.78(dd,1H),4.63(m,1H),4.72(dd,1H),4.8
0(s,2H)13 C-NMR (in CDCl3):d 55.0,58.0,79.1,79.577 Se-NMR (in CDCl3):d 941.8 元素分析:C 26.16%,H 4.17% (calc. C 26.24%,H 4.
405%)Melting point 123.8-125.2 ° C. 1 H-NMR (in CDCl 3): d 2.87 (d, 1H), 3.08 (dd, 1H), 3.58
(dd, 1H), 3.78 (dd, 1H), 4.63 (m, 1H), 4.72 (dd, 1H), 4.8
0 (s, 2H) 13 C-NMR (in CDCl3): d 55.0, 58.0, 79.1, 79.5 77 Se-NMR (in CDCl3): d 941.8 Elemental analysis: C 26.16%, H 4.17% (calc. C 26.24% , H 4.
(405%)
【0030】実施例4 化合物(2)(2,3−ジヒドロキシ−1,4−ブタン
ジセレノール)の合成 実施例1で合成した1,2−ジセレナン−4,5−ジオ
ール68.6mg(0.279mmol)をメタノール
0.5mLに溶解し、この溶液に水素化ホウ素ナトリウ
ムを溶液の色が消失するまで加えた。反応液に6M塩酸
6mLとエーテル80mLを加えて1時間激しく撹拌し
ながらエーテル抽出した。抽出は2回行い、エーテル層
をシリンジで採取して硫酸マグネシウム上で乾燥した。
溶媒を留去し、白色結晶状の目的化合物を得た。Example 4 Synthesis of compound (2) (2,3-dihydroxy-1,4-butanediselenol) 68.6 mg of 1,2-diselenane-4,5-diol synthesized in Example 1 (0.4%). 279 mmol) was dissolved in 0.5 mL of methanol, and sodium borohydride was added to the solution until the color of the solution disappeared. 6 mL of 6M hydrochloric acid and 80 mL of ether were added to the reaction solution, and ether extraction was performed with vigorous stirring for 1 hour. The extraction was performed twice, and the ether layer was collected with a syringe and dried over magnesium sulfate.
The solvent was distilled off to obtain a white crystalline target compound.
【0031】1H-NMR (in CDCl3):d -0.51(t,2H),2.82
(m,4H),4.27(m,2H)13 C-NMR (in CDCl3):d 22.6,80.777 Se-NMR (in CDCl3):d -78.3 元素分析:C 26.16%,H 4.17% (calc. C 26.24%,H 4.
405%) 1 H-NMR (in CDCl 3): d −0.51 (t, 2H), 2.82
(m, 4H), 4.27 ( m, 2H) 13 C-NMR (in CDCl3): d 22.6,80.7 77 Se-NMR (in CDCl3): d -78.3 Elemental analysis: C 26.16%, H 4.17% (calc. C 26.24%, H 4.
(405%)
【0032】比較例1 化合物(4)の酸化反応性 化合物(4)とDTT(1,4−ジメルカプト−2,3
−ブタンジオール)とを、1:1の比率でpH7.0の
緩衝液中に0.1M濃度で溶解したところ、速やかに化
合物(3)と1,2−ジチアン−4,5−ジオールに変
化した。すなわち、化合物(4)は強い酸化能力を持つ
ことが判った。Comparative Example 1 Oxidation Reactivity of Compound (4) Compound (4) and DTT (1,4-dimercapto-2,3)
-Butanediol) was dissolved at a concentration of 0.1 M in a buffer solution having a pH of 1: 1 at a ratio of 1: 1 and rapidly changed to the compound (3) and 1,2-dithiane-4,5-diol. did. That is, it was found that the compound (4) had a strong oxidizing ability.
【0033】比較例2 緩衝液のpHを4.0に変更した以外は比較例1と同様
の操作を行ったところ、やはり化合物(3)と1,2−
ジチアン−4,5−ジオールが得られた。Comparative Example 2 The same operation as in Comparative Example 1 was carried out except that the pH of the buffer was changed to 4.0.
Dithiane-4,5-diol was obtained.
【0034】比較例3 緩衝液のpHを8.0に変更した以外は比較例1と同様
の操作を行ったところ、やはり化合物(3)と1,2−
ジチアン−4,5−ジオールが得られた。Comparative Example 3 The same operation as in Comparative Example 1 was carried out except that the pH of the buffer solution was changed to 8.0.
Dithiane-4,5-diol was obtained.
【0035】比較例4 DTTをグルタチオンに変更した以外は比較例1と同様
な操作を行ったところ、化合物(3)が得られた。グル
タチオンの酸化物は同定できなかった。Comparative Example 4 The same operation as in Comparative Example 1 was carried out except that DTT was changed to glutathione, whereby a compound (3) was obtained. Glutathione oxide could not be identified.
【0036】比較例5 ジフェニルジスルフィド(PhSSPh)に対する反応
性 重メタノールを溶媒とし、NMRサンプル管に化合物
(2)とジフェニルジスルフィドを入れてNMR分析を
行ったところ、化合物(2)の消失と化合物(1)およ
びPhSHの生成が、lH、13C、77Se−NMRによ
って確認された。一方、DTTを用いた場合には、空気
酸化によると思われる1,2−ジチアン−4,5−ジオ
ールの生成がわずかに観測されたものの、PhSHの生
成は明確には確認できなかった。以上の結果より、化合
物(2)はDTTに比べ還元反応性が高いことが判っ
た。Comparative Example 5 Reactivity to diphenyl disulfide (PhSSPh) Compound (2) and diphenyl disulfide were placed in an NMR sample tube using heavy methanol as a solvent, and NMR analysis was carried out. 1) and the formation of PhSH were confirmed by 1 H, 13 C, 77 Se-NMR. On the other hand, when DTT was used, although the production of 1,2-dithiane-4,5-diol, which was considered to be due to air oxidation, was slightly observed, the production of PhSH was not clearly confirmed. From the above results, it was found that the compound (2) had a higher reduction reactivity than DTT.
【0037】比較例6 文献(J.Am.Chem.Soc.,1994,11
6,2557)記載の方法に従い、メタノール中の過酸
化水素水および2当量のチオフェノールに、化合物
(1)を10mol%加えた。PhSSPhによる30
5nmのUV吸収強度の変化より,各時間におけるPh
SH濃度を求め,1/v対1/[PhSH]プロット
(Lineweaver−Burk Plot)より初
期反応速度を求めた。初期条件としては,[H2O2]=
30mM、[PhSH]=1mM、[catalys
t]=0.01mMとした。(H2O2の初期濃度の設定
が文献のTable 1とは異なる)。得られた初期反
応速度(v0)は、触媒なしの場合、5.2microMole/m
inであったのに対し、化合物(1)を添加した場合、
7.9microMole/minという値であった。Comparative Example 6 Literature (J. Am. Chem. Soc., 1994, 11)
6,2557), 10 mol% of compound (1) was added to aqueous hydrogen peroxide and 2 equivalents of thiophenol in methanol. 30 by PhSSPh
From the change in UV absorption intensity at 5 nm, Ph at each time
The SH concentration was determined, and the initial reaction rate was determined from a 1 / v vs. 1 / [PhSH] plot (Lineweaver-Burk Plot). As initial conditions, [H 2 O 2 ] =
30 mM, [PhSH] = 1 mM, [catalys
t] = 0.01 mM. (Setting of the initial concentration of H 2 O 2 is different from Table 1 in the literature). The obtained initial reaction rate (v0) is 5.2 microMole / m when no catalyst is used.
Whereas, when compound (1) was added,
The value was 7.9 microMole / min.
【0038】比較例7 化合物(1)を化合物(3)に代えた以外は比較例6と
同様な操作を行ったところ、反応速度が8.4 microMo
le/minになった。Comparative Example 7 The same operation as in Comparative Example 6 was carried out except that Compound (1) was replaced with Compound (3), and the reaction rate was 8.4 microMo.
le / min.
【0039】[0039]
【発明の効果】本発明により、従来の蛋白質変成剤であ
るDTTおよびその誘導体である1,2−ジチアン−
4,5−ジオールよりも、中性付近で高い反応性を持つ
新規なセレン化合物類を見出した。生体反応触媒として
の効果も期待される。Industrial Applicability According to the present invention, the conventional protein denaturant DTT and its derivative 1,2-dithiane-
Novel selenium compounds having higher reactivity near neutrality than 4,5-diol have been found. An effect as a biological reaction catalyst is also expected.
Claims (11)
合物を作用させることを特徴とする、請求項1に記載の
式(1)で表される化合物の製造方法。 M2Se2 (6) (式中、MはLi,NaまたはKである。)5. The formula (5) The method for producing a compound represented by the formula (1) according to claim 1, wherein a selenium compound represented by the general formula (6) is caused to act on the compound represented by the formula (6). M 2 Se 2 (6) (where M is Li, Na or K)
Naである、請求項1に記載の式(1)で表される化合
物の製造方法。6. The method for producing a compound represented by the formula (1) according to claim 1, wherein M in the general formula (6) is Na.
合物に、一般式(7)で表される還元剤を作用させるこ
とを特徴とする、請求項2に記載の式(2)で表される
化合物の製造方法。 MBH4 (7) (式中、MはLi、NaまたはKである。)7. The compound according to claim 2, wherein the compound represented by the formula (1) according to claim 1 is reacted with a reducing agent represented by the formula (7). A method for producing the compound represented by 2). MBH 4 (7) (where M is Li, Na or K)
Naである、請求項2に記載の式(2)で表される化合
物の製造方法。8. The method for producing a compound represented by the formula (2) according to claim 2, wherein M in the general formula (7) is Na.
合物に、一般式(8)で表されるセレン化合物を作用さ
せることを特徴とする、請求項3に記載の式(3)で表
される化合物の製造方法。 MHSe (8) (式中、MはLi,NaまたはKである。)9. The compound according to claim 3, wherein the selenium compound represented by the general formula (8) acts on the compound represented by the formula (5) according to claim 5. A method for producing the compound represented by 3). MHSe (8) (where M is Li, Na or K)
がNaである、請求項3に記載の式(3)で表される化
合物の製造方法。10. The method according to claim 9, wherein M
Is a method for producing a compound represented by the formula (3) according to claim 3.
化合物に、有機過酸化物を作用させることを特徴とす
る、請求項4に記載の式(4)で表される化合物の製造
方法。11. The compound represented by the formula (4) according to claim 4, wherein an organic peroxide is allowed to act on the compound represented by the formula (3) according to claim 3. Manufacturing method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24168699A JP4433521B2 (en) | 1999-08-27 | 1999-08-27 | New selenium compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24168699A JP4433521B2 (en) | 1999-08-27 | 1999-08-27 | New selenium compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001064279A true JP2001064279A (en) | 2001-03-13 |
| JP4433521B2 JP4433521B2 (en) | 2010-03-17 |
Family
ID=17078018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24168699A Expired - Fee Related JP4433521B2 (en) | 1999-08-27 | 1999-08-27 | New selenium compounds |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4433521B2 (en) |
-
1999
- 1999-08-27 JP JP24168699A patent/JP4433521B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4433521B2 (en) | 2010-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004534053A (en) | Crystalline cefdinir acid addition salt and method for producing cefdinir using the same | |
| JP2020097607A (en) | Novel manufacturing method of chromanone derivative | |
| CN102939298B (en) | Prepare the method for pteridine derivatives | |
| JPH0150704B2 (en) | ||
| WO2005035538A1 (en) | Penam crystal and process for producing the same | |
| KR20030060901A (en) | A process for the preparation of pantoprazole and intermediates therefor | |
| US7244865B2 (en) | Process for preparing benzhydrylthioacetamide | |
| EP1503983B1 (en) | A process for the preparation of modafinil | |
| JP4433521B2 (en) | New selenium compounds | |
| JPWO1996019448A1 (en) | Method for producing bis(4-alkylthiophenyl) disulfide | |
| US7109353B2 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl | |
| CN101163671A (en) | The preparation method of hydrazone derivative | |
| EP1678129B1 (en) | Improved process for preparing benzhydrylthioacetamide | |
| EP0675877A1 (en) | A process for preparing sulfones | |
| JP2003508521A (en) | Method for producing 1-substituted 5-hydroxymethylimidazole | |
| EP3162795B1 (en) | Method for manufacturing 3-(alkyl sulfonyl)pyridine-2-carboxylic acid | |
| CN103497159B (en) | 1,2-bis-replaces the preparation method of-5-sulfonylimidazoles compounds | |
| CN121108046A (en) | A method for preparing 3-hydroxylated quinoline-2,4-dione compounds | |
| WO2025257737A1 (en) | Process for the preparation of urolithin a and analogues thereof | |
| KR100502390B1 (en) | Process for preparing cephalosporinic acid | |
| JPH0480918B2 (en) | ||
| JPS6254303B2 (en) | ||
| JP2003002878A (en) | Method for preparing 2-aminophenoxazin-3-one derivative or 3-aminophenoxazin-2-one derivative | |
| JP2002003491A (en) | Method for producing 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine | |
| JPH0532649A (en) | Production of optically active benzyl glycidyl ether |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060609 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20091208 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20091221 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130108 Year of fee payment: 3 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130108 Year of fee payment: 3 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130108 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130108 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140108 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |